Christopher Goetz to Antipsychotic Agents
This is a "connection" page, showing publications Christopher Goetz has written about Antipsychotic Agents.
Connection Strength
1.637
-
An update expert opinion on management and research strategies in Parkinson's disease psychosis. Expert Opin Pharmacother. 2011 Sep; 12(13):2009-24.
Score: 0.387
-
Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening. Mov Disord. 2008 Aug 15; 23(11):1541-5.
Score: 0.319
-
Therapies for movement disorders. Arch Neurol. 2002 May; 59(5):699-702.
Score: 0.206
-
Association between antipsychotics and body mass index when treating patients with tics. J Child Adolesc Psychopharmacol. 2010 Aug; 20(4):277-81.
Score: 0.091
-
Hallucinations in Parkinson disease. Nat Rev Neurol. 2009 Jun; 5(6):331-42.
Score: 0.084
-
Epidemiology and pathophysiology of tardive dyskinesias. Adv Neurol. 1988; 49:185-97.
Score: 0.076
-
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease. Mov Disord. 2006 Dec; 21(12):2078-81.
Score: 0.071
-
Gilles de la Tourette syndrome: patient's knowledge and concern of adverse effects. Mov Disord. 2006 Feb; 21(2):248-52.
Score: 0.067
-
Drug-induced Parkinsonism and idiopathic Parkinson's disease. Arch Neurol. 1983 May; 40(5):325-6.
Score: 0.055
-
Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study. J Am Acad Child Adolesc Psychiatry. 2000 Mar; 39(3):292-9.
Score: 0.044
-
Parkinson's disease. Clin Neuropharmacol. 1999 Jul-Aug; 22(4):184-91.
Score: 0.042
-
Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome. Mov Disord. 1998 May; 13(3):477-80.
Score: 0.039
-
Pediatric clozapine intoxication. Am J Emerg Med. 1996 Sep; 14(5):462-3.
Score: 0.035
-
A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol. 2010 Aug; 67(8):996-1001.
Score: 0.023
-
The autonomic nervous system in Gilles de la Tourette's syndrome. Mov Disord. 1987; 2(2):99-102.
Score: 0.018
-
The pathophysiology of tardive dyskinesia. J Clin Psychiatry. 1985 Apr; 46(4 Pt 2):38-41.
Score: 0.016
-
Objective assessments of longitudinal outcome in Gilles de la Tourette's syndrome. Neurology. 2003 Oct 14; 61(7):936-40.
Score: 0.014
-
Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology. 2003 Jun 10; 60(11):1756-61.
Score: 0.014
-
Animal models of tardive dyskinesia: their use in the search for new treatment methods. Mod Probl Pharmacopsychiatry. 1983; 21:5-20.
Score: 0.014
-
Drug-induced extrapyramidal disorders - a neuropsychiatric interface. J Clin Psychopharmacol. 1981 Sep; 1(5):297-303.
Score: 0.012
-
Animal models of tardive dyskinesias. Clin Neuropharmacol. 1983 Jun; 6(2):129-35.
Score: 0.003
-
Anticholinergics and tardive dyskinesia. Am J Psychiatry. 1980 Nov; 137(11):1470-1.
Score: 0.003
-
Tardive dyskinesia: review and update. Am J Psychiatry. 1980 Aug; 137(8):900-8.
Score: 0.003